138 related articles for article (PubMed ID: 8422404)
41. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
42. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
Buzón V; Cladera J
Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
[TBL] [Abstract][Full Text] [Related]
43. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.
Kliger Y; Shai Y
Biochemistry; 1997 Apr; 36(17):5157-69. PubMed ID: 9136877
[TBL] [Abstract][Full Text] [Related]
44. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide.
Yang J; Gabrys CM; Weliky DP
Biochemistry; 2001 Jul; 40(27):8126-37. PubMed ID: 11434782
[TBL] [Abstract][Full Text] [Related]
45. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
[TBL] [Abstract][Full Text] [Related]
46. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.
Rafalski M; Lear JD; DeGrado WF
Biochemistry; 1990 Aug; 29(34):7917-22. PubMed ID: 2261447
[TBL] [Abstract][Full Text] [Related]
47. Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models.
Agopian A; Castano S
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):117-26. PubMed ID: 24055820
[TBL] [Abstract][Full Text] [Related]
48. Changes in lipid bilayer structure caused by the helix-to-sheet transition of an HIV-1 gp41 fusion peptide derivative.
Heller WT; Rai DK
Chem Phys Lipids; 2017 Mar; 203():46-53. PubMed ID: 28104377
[TBL] [Abstract][Full Text] [Related]
49. On the microscopic and mesoscopic perturbations of lipid bilayers upon interaction with the MPER domain of the HIV glycoprotein gp41.
Oliva R; Emendato A; Vitiello G; De Santis A; Grimaldi M; D'Ursi AM; Busi E; Del Vecchio P; Petraccone L; D'Errico G
Biochim Biophys Acta; 2016 Aug; 1858(8):1904-13. PubMed ID: 27179640
[TBL] [Abstract][Full Text] [Related]
50. Interfacial properties and structure stability of the gp41 tryptophan-rich peptide from HIV-1.
Matar G; Nasir MN; Besson F
J Colloid Interface Sci; 2010 Dec; 352(2):520-5. PubMed ID: 20850757
[TBL] [Abstract][Full Text] [Related]
51. Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide.
Yang J; Weliky DP
Biochemistry; 2003 Oct; 42(40):11879-90. PubMed ID: 14529300
[TBL] [Abstract][Full Text] [Related]
52. Fusion-competent state induced by a C-terminal HIV-1 fusion peptide in cholesterol-rich membranes.
Apellániz B; Nieva JL
Biochim Biophys Acta; 2015 Apr; 1848(4):1014-22. PubMed ID: 25617671
[TBL] [Abstract][Full Text] [Related]
53. Efficient Fusion at Neutral pH by Human Immunodeficiency Virus gp41 Trimers Containing the Fusion Peptide and Transmembrane Domains.
Liang S; Ratnayake PU; Keinath C; Jia L; Wolfe R; Ranaweera A; Weliky DP
Biochemistry; 2018 Feb; 57(7):1219-1235. PubMed ID: 29345922
[TBL] [Abstract][Full Text] [Related]
54. Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes.
Slepushkin VA; Melikyan GB; Sidorova MS; Chumakov VM; Andreev SM; Manulyan RA; Karamov EV
Biochem Biophys Res Commun; 1990 Oct; 172(2):952-7. PubMed ID: 2173585
[TBL] [Abstract][Full Text] [Related]
55. Comparison of lipid vesicle fusion induced by the putative fusion peptide of fertilin (a protein active in sperm-egg fusion) and the NH2-terminal domain of the HIV2 gp41.
Martin I; Ruysschaert JM
FEBS Lett; 1997 Apr; 405(3):351-5. PubMed ID: 9108317
[TBL] [Abstract][Full Text] [Related]
56. 13C-13C and (15)N-(13)C correlation spectroscopy of membrane-associated and uniformly labeled human immunodeficiency virus and influenza fusion peptides: amino acid-type assignments and evidence for multiple conformations.
Bodner ML; Gabrys CM; Struppe JO; Weliky DP
J Chem Phys; 2008 Feb; 128(5):052319. PubMed ID: 18266436
[TBL] [Abstract][Full Text] [Related]
57. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
Muñoz-Barroso I; Durell S; Sakaguchi K; Appella E; Blumenthal R
J Cell Biol; 1998 Jan; 140(2):315-23. PubMed ID: 9442107
[TBL] [Abstract][Full Text] [Related]
58. Cholesterol Modulates Membrane Properties and the Interaction of gp41 Fusion Peptide To Promote Membrane Fusion.
Meher G; Sinha S; Pattnaik GP; Ghosh Dastidar S; Chakraborty H
J Phys Chem B; 2019 Aug; 123(33):7113-7122. PubMed ID: 31345037
[TBL] [Abstract][Full Text] [Related]
59. Molecular dynamics simulation of HIV-1 fusion domain-membrane complexes: Insight into the N-terminal gp41 fusion mechanism.
Promsri S; Ullmann GM; Hannongbua S
Biophys Chem; 2012; 170():9-16. PubMed ID: 22892124
[TBL] [Abstract][Full Text] [Related]
60. Unsaturated Lipid Accelerates Formation of Oligomeric β-Sheet Structure of GP41 Fusion Peptide in Model Cell Membrane.
Wang W; Tan J; Ye S
J Phys Chem B; 2020 Jun; 124(25):5169-5176. PubMed ID: 32453953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
